Search criteria | ||||
Effectively Leveraging RWD for External Controls: A Systematic Literature Review of Regulatory and HTA Decisions | ||||
Oriol Sola- Morales (1), Lesley H. Curtis (2), Julien Heidt (3),*, Laura Walsh (4), Deborah Casso (5),?, Susan Oliveria (6),?, Patrick Saunders- Hastings (7), Yufei Song (8),?, Tiffany Mercado (3), Robbert Zusterzeel (3),?, Vera Mastey (9), James Harnett (9) and Ruben G. W. Quek (9) | ||||
(1) Fundació Health Innovation Technology Transfer and International, University of Catalonia, Barcelona, Spain; (2) Duke Clinical Research Institute, Durham, North Carolina, USA; (3) IQVIA, Regulatory Science and Strategy, Falls Church, Virginia, USA; (4) IQVIA, Epidemiology and Drug Safety Practice, Boston, Massachusetts, USA; (5) IQVIA, Epidemiology and Drug Safety Practice, Seattle, Washington, USA; (6) IQVIA, Epidemiology and Drug Safety Practice, New York, New York, USA; (7) Epi Excellence LLC, Garnet Valley, Pennsylvania, USA; (8) IQVIA, Epidemiology and Drug Safety Practice, Beijing, China; (9) Regeneron Pharmaceuticals Inc., Health Economics & Outcomes Research, Tarrytown, New York, USA | ||||
Clinical pharmacology and therapeutics vol. 114,2 (2023): 325-355. doi:10.1002/cpt.2914 |
||||
, Article | ||||
, Europe, USA | ||||
Abstract: https://ascpt.onlinelibrary.wiley.com/doi/epdf/10.1002/cpt.2914 | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Methodology, Regulatory | 2023 | English | , Review | |
Regulatory and HTA Considerations for Development of Real- World Data Derived External Controls | ||||
Lesley H. Curtis (1), Oriol Sola-Morales (2), Julien Heidt (3),*, Patrick Saunders- Hastings (4), Laura Walsh (5), Deborah Casso (6),?, Susan Oliveria (7),?, Tiffany Mercado (3), Robbert Zusterzeel (3),?, Rachel E. Sobel (8), Jessica J. Jalbert (9), Vera Mastey (9), James Harnett (9) and Ruben G. W. Quek (9) | ||||
1Duke Department of Population Health Sciences and Duke Clinical Research Institute, Durham, North Carolina, USA; 2Fundació HiTT and Universitat Internacional de Catalunya (UIC), Barcelona, Spain; 3IQVIA, Regulatory Science and Strategy, Falls Church, Virginia, USA; 4Epi Excellence LLC, Garnet Valley, Pennsylvania, USA; 5IQVIA, Epidemiology and Drug Safety Practice, Boston, Massachusetts, USA; 6IQVIA, Epidemiology and Drug Safety Practice, Seattle, Washington, USA; 7IQVIA, Epidemiology and Drug Safety Practice, New York, New York, USA; 8Regeneron Pharmaceuticals Inc., Pharmacoepidemiology, Tarrytown, New York, USA; 9Regeneron Pharmaceuticals Inc., Health Economics & Outcomes Research, Tarrytown, New York, USA. | ||||
Clin Pharmacol Ther, 114: 303-315. https://doi.org/10.1002/cpt.2913 |
||||
, Article | ||||
, USA | ||||
Abstract: https://ascpt.onlinelibrary.wiley.com/doi/epdf/10.1002/cpt.2913 | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Methodology, Regulatory | 2023 | English | , Review | |
How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment tools | ||||
Elvira D'Andrea, Lydia Vinals, Elisabetta Patorno, Jessica M. Franklin, Dimitri Bennett , Joan A. Largent, Daniela C. Moga, Hongbo Yuan, Xuerong Wen, Andrew R. Zullo, Thomas P. A. Debray, Grammati Sarri | ||||
D'Andrea: Harvard; Largent: IQVIA | ||||
http://orcid.org/0000-0002-5263-3964PubMed articles |
||||
, Article | ||||
, Europe, USA | ||||
Abstract: https://bmjopen.bmj.com/content/11/3/e043961 | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2021 | English | , Literature Review | |
Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making | ||||
Grammati Sarri 1, Elisabetta Patorno 2, Hongbo Yuan 3, Jianfei Jeff Guo 4, Dimitri Bennett 5, Xuerong Wen 6, Andrew R Zullo 7, Joan Largent 8, Mary Panaccio 9, Mugdha Gokhale 10, Daniela Claudia Moga 11, M Sanni Ali 12 13 14, Thomas P A Debray 15 16 | ||||
1Real World Evidence Sciences, Visible Analytics Ltd, Oxford, UK grammati.sarri@visibleanalytics.co.uk. 2Division of Pharmacoepidemiology and Pharmacoeconomics, Dept. of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. 3Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, Ontario, Canada. 4Department of Pharmacy Practice & Administrative Sciences, University of Cincinnati College of Pharmacy, Cincinnati, Ohio, USA. 5Takeda, Cambridge, Massachusetts, USA. 6Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA. 7Health Services, Policy, and Practice, Brown University, Providence, Rhode Island, USA. 8Real-World Solutions, IQVIA, California, Colorado, USA. 9Epidemiology and Outcomes Research, Research Outcomes Innovations LLC, New York City, New York, USA. 10GlaxoSmithKline USA, Philadelphia, Pennsylvania, USA. 11University of Kentucky, Department of Pharmacy Practice and Science, Lexington, Kentucky, USA. 12NDORMS, Center for Statistics in Medicine, University of Oxford, Oxford, UK. 13Department of Non-communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine (LSHTM), London, UK. 14Department of Public Heath, Environments and Society, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine (LSHTM), London, UK. 15Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands. 16Smart Data Analysis and Statistics, Utrecht, The Netherlands. | ||||
PMID: 33298465 DOI: 10.1136/bmjebm-2020-111493 |
||||
, Article | ||||
, Europe, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33298465/ | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2021 | English | , Literature Review | |
Clinical and Economic Burden of Mild-to-Moderate Atopic Dermatitis in the UK: A Propensity-Score-Matched Case-Control Study | ||||
Farah Toron 1, Maureen P Neary 2, Timothy W Smith 3, David Gruben 4, William Romero 5, Amy Cha 3, Keyur Patel 1, Simona Z Vasileva 6, Mahreen Ameen 7 | ||||
1Health Economics and Outcomes Research, Real World Solutions, IQVIA, 210 Pentonville Road, London, N1 9JY, UK. 2Inflammation & Immunology, Pfizer Inc, Collegeville, Pennsylvania, USA. 3Inflammation & Immunology, Pfizer Inc, New York, New York, USA. 4Global Biometrics and Data Management (Statistics), Pfizer Inc, Groton, Connecticut, USA. 5Inflammation & Immunology, Pfizer Ltd, Surrey, UK. 6Health Economics and Outcomes Research, Real World Solutions, IQVIA, 210 Pentonville Road, London, N1 9JY, UK. simona.vasileva@iqvia.com. 7Royal Free London National Health Services Foundation Trust, London, UK. | ||||
PMID: 33846907 PMCID: PMC8163940 DOI: 10.1007/s13555-021-00519-7 |
||||
, Article | ||||
, UK | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33846907/ | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Drug Utlization Study, Methodology | 2021 | English | , direct to patient research, direct-to-patient research, Economic evaluation, Population Based Study, Retrospective database analysis | |
A review of the sampling methodology used in studies evaluating the effectiveness of risk minimisation measures in Europe. | ||||
Jouaville LS, Paul T, Almas MF | ||||
IQVIA | ||||
Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1143-1152. doi: 10.1002/pds.5301. |
||||
, Article | ||||
, Europe | ||||
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/pds.5301 | ||||
Condition | Year | Language | Analysis type | |
, Guidelines, Methodology, Risk Management & REMS | 2021 | English | , Literature Review | |
Comparison of ICD-9-CM to ICD-10-CM Crosswalks Derived by Physician and Clinical Coder vs. Automated Methods | ||||
Jason C Simeone, Xinyue Liu, Tarun Bhagnani, Matthew W Reynolds, Jenna Collins, Edward A Bortnichak | ||||
CAEG | ||||
Perspective Health Information Management 2021 Mar 15;18(Spring):1e. |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34035786/ | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2021 | English | ||
When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments? | ||||
Jessica M Franklin 1 2, Richard Platt 3, Nancy A Dreyer 4, Alex John London 5, Gregory E Simon 6, Jonathan H Watanabe 7, Michael Horberg 8, Adrian Hernandez 9, Robert M Califf 10 | ||||
1Optum Epidemiology, Boston, Massachusetts, USA. 2Division of Pharmacoepidemiology & Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. 3Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA. 4IQVIA Real World Solutions, Cambridge, Massachusetts, USA. 5Philosophy Department & Center for Ethics and Policy, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA. 6Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA. 7School of Pharmacy and Pharmaceutical Sciences, University of California Irvine, Irvine, California, USA. 8Kaiser Permanente Mid-Atlantic Permanente Research Institute and Mid-Atlantic Permanente Medical Group, Bethesda, Maryland, USA. 9Duke Clinical Research Institute, Durham, North Carolina, USA. 10Verily Life Sciences and Google Health, Cambridge, Massachusetts, USA. | ||||
Clinical Pharmacology & Therapeutics. 2021 Apr 7. |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33826756/ | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2021 | English | , Real World Data | |
Uncontrolled Extensions of Clinical Trials and the Use of External Controls–scoping opportunities and methods. | ||||
Ching-Yu Wang 1, Jesse A Berlin 2, Barry Gertz 3, Kourtney Davis 4, Jie Li 5, Nancy A Dreyer 6, Wei Zhou 7, John D Seeger 8, Nancy Santanello 9, Almut G Winterstein 1 | ||||
1Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety, University of Florida, Gainesville, Florida, USA. 2Epidemiology, Johnson & Johnson, Titusville, New Jersey, USA. 3Blackstone Life Sciences, Cambridge, Massachusetts, USA. 4Global Epidemiology, Janssen R&D, Titusville, New Jersey, USA. 5US Food and Drug Administration, Silver Spring, Maryland, USA. 6Real-World Solutions, IQVIA, Cambridge, Massachusetts, USA. 7Merck & Co., Inc., Kenilworth, New Jersey, USA. 8Optum, Boston, Massachusetts, USA. 9Pharmacoepidemiology Consultant, New Hope, Pennsylvania, USA. | ||||
Clinical Pharmacology & Therapeutics. 2021 Jun 24. |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34165790/ | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2021 | English | , Real World Data | |
A review of the sampling methodology used in studies evaluating the effectiveness of risk minimisation measures in Europe | ||||
Laurence Sophie Jouaville 1, Tulika Paul 2, Mariana Ferreira Almas | ||||
QVIA Real World Solutions, La Defense, France. 2IQVIA Real World Solutions, Gurugram, Haryana, India. 3IQVIA Real World Solutions, Porto Salvo, Portugal. | ||||
Pharmacoepidemiol Drug Saf . 2021 Sep;30(9):1143-1152. doi: 10.1002/pds.5301. Epub 2021 Jun 24. |
||||
, Article | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34092001/ | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Risk Management & REMS | 2021 | English | , Database Study | |
Replication of randomized clinical trial results using real-world data: paving the way for effectiveness decisions | ||||
Kristin M Sheffield , Nancy A Dreyer , James F Murray, Douglas E Faries & Megan N Klopchin | ||||
1Global Patient Outcomes & Real World Evidence, Eli Lilly & Company, Indianapolis, IN 46225, USA 2IQVIA Real-World & Analytic Solutions, Cambridge, MA 02139, USA 3Real World Analytics, Eli Lilly & Company, Indianapolis, IN 46225, USA | ||||
Published Online:11 Sep 2020https://doi.org/10.2217/cer-2020-0161 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.futuremedicine.com/doi/10.2217/cer-2020-0161 | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Drug Utlization Study, Guidelines, Methodology, Public Health | 2020 | English | , Methodology, Observational study, Population Based Study | |
Evidence synthesis in pulmonary arterial hypertension: a systematic review and critical appraisal | ||||
Max Schlueter, Amélie Beaudet, Evan Davies, Binu Gurung, Andreas Karabis | ||||
IQVIA, 210 Pentonville Road, London, N1 9JY; IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, Netherlands; Department of Statistical Science, University College London, London, WC1E 6BT, UK. | ||||
, Article | ||||
Abstract: https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-020-01241-4 | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Methodology, Rare Diseases | 2020 | English | , Literature Review, Review | |
A quantitative bias analysis of the confounding effects due to smoking on the association between fluoroquinolones and risk of aortic aneurysm. | ||||
Zhang M, Falconer M, Taylor LG | ||||
"1Division of Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA. 2Real World Solutions, IQVIAâ„¢, Durham, North California, USA." | ||||
Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):958-961. doi: 10.1002/pds.5019. Epub 2020 May 13.PMID: 32406104 |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32406104/ | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Methodology | 2020 | English | , Observational study | |
When Context Is Hard to Come By: External Comparators and How to Use Them. | ||||
Mack C, Christian J, Brinkley E, Warren EJ, Hall M, Dreyer N | ||||
IQVIA Real-World & Analytic Solutions, Durham, NC, USA. IQVIA Real-World & Analytic Solutions, Rockville, MD, USA. IQVIA Real-World & Analytic Solutions, Cambridge, MA, USA | ||||
Ther Innov Regul Sci. 2019 Nov 5:2168479019878672. |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31690113 | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2019 | English | , Retrospective database analysis | |
Natural hisotry of oral human papillomavirus infection in healthy populations: Design of the Prevalence of Oral HPV infection, a Global assessment, THE PROGRESS STUDY | ||||
Pedros M1, Morais E2, Roset M1, Kothari S3, Alemany L5, Mirghani H6, Mehanna H7, Waterboer T8, Roberts C3, Vendetti N3, Walia A3, Drury R2, Luxembourg A3, Giuliano A9 | ||||
1 IQVIA, Barcelona, Spain 2 MSD, Lyon, France 3 Merck & Co, Inc., Kenilworth, NJ, US 5 Catalan Institute of Oncology, Cancer Epidemiology Research Program and IDIBELL i CIBERESP, Barcelona, Spain 6 Hôpital Européen Georges-Pompidou Université Paris-Descartes, Paris, France 7 Institute of Head & Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, United kingdom 8 German Cancer Research Center (DKFZ), Heidelberg, Germany 9 Moffitt Cancer Center, Florida, US | ||||
EUROGIN, Monaco, France, 4-7 December 2019 |
||||
, Oral presentation | ||||
, China, France, Germany, Italy, Japan, Spain, UK, USA | ||||
Abstract: http://merck.creative.studios.s3-website-us-east-1.amazonaws.com/EUROGIN_2019/2019_EUROGIN_Pedros_NaturalHistory.pdf | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Infectious disease, Methodology | 2019 | English | , Epidemiological study, Observational study, Population Based Study | |
Methodologic considerations for non-interventional studies evaluating outcomes of originator-to-biosimilar switching | ||||
Desai R, Kim S, Gagne J, Curtis J, Bosco J, Bradbury B. | ||||
Pharmacoepidemiol Drug Saf 2018; 27 (2): 4-5 |
||||
, Symposium | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2018 | English | ||
When and where to use blinding in pragmatic trials. | ||||
Christian J, Brouwer E, Davis K, Bennett D, Dreyer N, Girman C. | ||||
Pharmacoepidemiol Drug Saf 2018; 27 (2):203-204. |
||||
Condition | Year | Language | Analysis type | |
, Methodology | 2018 | English | ||
ASSESSMENT OF THE UNIT COSTS IN IMAGING ACTS: THE EXAMPLE OF MRI AND CT-SCAN ACTS IN France | ||||
Vasilescu L., Faller M., Allou A. | ||||
IQVIA France - RWI | ||||
ISPOR 2018 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Methodology | 2018 | English | , Literature Review, Public Health, Review | |
A Second Look at NBA Game Schedules: Response to Teramoto et al. | ||||
Mack CD, Herzog MM, DiFiori JP, Meisel PL, Dreyer NA | ||||
QuintilesIMS Real-World Insights, Research Triangle Park, USA. Electronic address: christina.mack@quintilesims.com. QuintilesIMS Real-World Insights, Research Triangle Park, USA. National Basketball Association, USA; Division of Sports Medicine and Non-Operative Orthopaedics, University of California Los Angeles, USA. National Basketball Association, USA. QuintilesIMS Real-World Insights, Cambridge, USA. | ||||
J Sci Med Sport. 2018 Mar;21(3):228-229 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28823474 | ||||
Condition | Year | Language | Analysis type | |
, Injuries, Methodology | 2018 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
Harmo an eletronic medicine diary designed to manage data on prescription at pharmacies on the cloud server and even more | ||||
A Igarashi 1, Sven Demiya 2, Eric Yu 2, G Fukushi 3, Y Takagi 3 (rwesheorj 2) | ||||
1) University of Tokyo, Tokyo, Japan 2) IMS Japan K.K., Tokyo, Japan 3) SONY Corp., Tokyo, Japan | ||||
ISPOR Asia Pacific 2018 Conference |
||||
, Abstract | ||||
, Japan | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/ispor-asia-pacific-2018/harmo-an-eletronic-medicine-diary-designed-to-manage-data-on-prescription-at-pharmacies-on-the-cloud-server-and-even-more | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2018 | English | , direct to patient research | |
Estimating glomerular filtration rate in primary care electronic medical record databases in Europe | ||||
Jouaville SL1, Bizouard G1, Boutmy E1, Keja J2 | ||||
1QuintilesIMS, Boulogne Billancourt, France, 2QuintilesIMS, Rotterdam, Netherlands | ||||
22nd ISPOR Annual International Meeting, Boston, 2017 |
||||
, Abstract | ||||
, Germany, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Methodology, Nephrology | 2017 | English | , Clinical setting: Primary care, Retrospective database analysis | |
EXTRAPOLATION OF ADULT DATA FOR PEDIATRIC DRUG BENEFIT ASSESSMENT IN THE AMNOG DOSSIER IN THE LIGHT OF THE NEW AMVSG | ||||
Stoecker P, Hofmann-Xu L, Bonduelle D | ||||
QuintilesIMS Health Germany, Munich, Germany | ||||
ISPOR Glasgow 2017 |
||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Pediatrics | 2017 | English | , Retrospective database analysis | |
The relationship of predicted benefits in life expectancy and quality adjusted life expectancy for improved glucose control in type 2 diabetes simulation modeling. | ||||
Ramos M1, McEwan P2, Lamotte M1, Foos V1 | ||||
1 QuintilesIMS, Zaventem, Belgium, 2 Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, Nov 4 - 8, 2017, Glasgow, Scotland, United Kingdom |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Methodology | 2017 | English | , Cost effectiveness | |
Developing a Multi-Phase Claims-Based Algorithm to Facilitate the Study of Drug Exposure During Pregnancy | ||||
Syd Phillips (1); Karin Johnson (1); Sophie Shen (2); Kimberley Woodcroft (3); Susan A Oliveria (4); Teresa Simon (2) | ||||
(1) IQVIA, Epidemiology and Drug Safety, Seattle, WA; (2) Bristol-Myers Squibb, Global Pharmacovigilance and Epidemiology, Hopewell, NJ (3); Henry Ford Health System, Department of Public Health Sciences, Detroit, MI; IQVIA, Epidemiology and Drug Safety, New York, NY | ||||
Conference: 2017 American College of Rheumatology Annual Meeting |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2017 | English | , Retrospective database analysis | |
Privacy, Confidentiality, Security, and Ethics | ||||
L. Arbuckle, M. Chibba, K. El Emam, A. Cavoukian | ||||
Department of Pediatrics, Faculty of Medicine, University of Ottawa, 401 Smyth Road, Ottawa, Canada K1H 8L1 Electronic Health Information Laboratory, Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Ottawa, Ontario, Canada K1H 8L1 | ||||
Population Health Informatics, Jones & Bartlett Learning |
||||
, Book | ||||
, Canada | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2017 | English | , De-identification / anonymisation | |
METHODOLOGICAL REVIEW OF SURVIVAL MODELS: APPLICATION TO A PERSISTENCE ANALYSIS BASED ON LONG ACTING PARENTERAL ANTIPSYCHOTIC IN RETAIL PHARMACIES IN FRANCE | ||||
Harmand S, El Mouaddin N | ||||
IMS Health France | ||||
19th ISPOR COngress 2016 |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance, Methodology | 2016 | English | , Compliance, Database Study, Methodology | |
STATISTICAL MODELS TO PREDICT INDICATION OF RESPIRATORY PATIENTS BETWEEN ASTHMA AND COPD | ||||
Ilgin Y, Staus A, Chauvin F, Leheyda N, Wolk A, Witte M, Subramani S | ||||
19th ISPOR congress 2016 |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes, Methodology, Respiratory disease | 2016 | English | , Methodology, Retrospective database analysis | |
Integrating the Patient Perspective Into Clinical Research Study Designs: Case Studies and Recommendations. | ||||
David Cameron | ||||
QuintilesIMS | ||||
Journal for Clinical Studies |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Methodology | 2016 | English | ||
Evidence generation from healthcare databases: recommendations for managing change | ||||
Alison Bourke, Andrew Bate, Brian C. Sauer, Jeffrey S. Brown and Gillian C. Hall | ||||
IMS Health, London, UK Pfizer, Tadworth, UK University of Utah School of Medicine, Salt Lake City, UT, USA Harvard Medical School, Boston, MA, USA Grimsdyke House, London, UK | ||||
Pharmacoepidemiology and Drug Safety |
||||
, Abstract | ||||
, UK, USA | ||||
Abstract: http://onlinelibrary.wiley.com/doi/10.1002/pds.4004/full | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2016 | English | ||
Quantifying the impact of different approaches for handling continuous predictors on the performance of a prognostic model | ||||
Collins GS, Ogundimu EO, Cook JA, Manach YL, Altman DG | ||||
Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford; Departments of Anesthesia and Clinical Epidemiology and Biostatistics, Michael DeGroote School of Medicine, Faculty of Health Sciences | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2016 | English | , Retrospective database analysis | |
Selection Bias When Using Instrumental Variable Methods to Compare Two Treatments But More Than Two Treatments Are Available. | ||||
Ertefaie A, Small D, Flory J, Hennessy S | ||||
Department of Statistics, Center for Pharmacoepidemiology Research and Training, University of Pennsylvania; Department of Statistics, University of Pennsylvania; Department of Statistics, University of Pennsylvania; Weill-Cornell School of Medicine | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2016 | English | , Retrospective database analysis | |
Instrumental variables analysis using multiple databases: an example of antidepressant use and risk of hip fracture | ||||
Uddin MJ, Groenwold RH, de Boer A, Gardarsdottir H, Martin E, Candore G, Belitser SV, Hoes AW, Roes KC, Klungel OH | ||||
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences; Department of Statistics, Shahjalal University of Science and Technology; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht; Department of Clinical Pharmacy, Division of Laboratory and Pharmacy; BIFAP Research Unit. Division of Pharmacoepidemiology and Pharmacovigilance; European Medicines Agency | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2016 | English | , Retrospective database analysis | |
Development and validation of an electronic frailty index using routine primary care electronic health record data | ||||
Andrew Clegg, Chris Bates , John Young , Ronan Ryan, Linda Nichols, Elizabeth, Ann Teale, Mohammed A. Mohammed, John Parry, Tom Marshall | ||||
University of Birmingham | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2016 | English | , Retrospective database analysis | |
Évaluation d’une base de données issue des dossiers médicaux informatisés d’un panel d’endocrinologues français | ||||
Christine Hellard, Sophie L. Jouaville, Simon Pilet, Adeline Meilhoc | ||||
IQVIA FRANCE | ||||
Rev Epidemiol Sante Publique |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2016 | French | , Observational study | |
Filling GAP between risk-benefit assessment for pharmaceutical products and consumer goods | ||||
Hofmann-Xu L1, Bonduelle D1, Plantör S1 | ||||
1 IMS Health GmbH & Co. OHG, Munich, Germany | ||||
18th International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Milan 2015 |
||||
, Poster | ||||
, Germany | ||||
Abstract: http://www.ispor.org/ | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2015 | English | , Real World Evidence | |
Reducing and quantifying over-fitting in regression models | ||||
Rigg J, Hankins M | ||||
IMS Health, London, UK | ||||
ISPOR 20th Annual International Meeting, May 16 - 20 2015, Philadelphia, PA USA |
||||
, Podium presentation | ||||
Abstract: http://www.ispor.org/Event/ProgramList/2015Philadelphia?type=Podium | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2015 | English | , Methodology | |
Longitudinal medical records as a complement to routine drug safety signal analysis | ||||
Star K, Watason S, Sandberg L, Johansson J, Edwards IR | ||||
Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring | ||||
Pharmacoepidemiology and Drug Safety published by John Wiley & Sons, Ltd. 24(5):486-94 |
||||
, Article | ||||
, UK | ||||
Abstract: http://onlinelibrary.wiley.com/doi/10.1002/pds.3739/full | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Methodology | 2015 | English | , Retrospective database analysis | |
Exploring innovative methods to identify patient subgroup treatment response | ||||
Rigg J,Hankins, M,Roddam A, Avorn A, Kim J | ||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2015 | English | , Methodology | |
Real-world treatment with abiraterone acetate (Zytiga®) in metastatic castration-resistant prostate cancer (mCRPC) patients in the post-chemotherapy setting in Europe | ||||
L Dearden, P Musingarimi, N Shalet, T Maher, D Demuth, L Garcia-Alvarez, A Muthutantri, A Venerus, R Lasry, M Hankins | ||||
, Conference | ||||
, Europe | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Oncology | 2015 | English | , Real World Data, Real World Evidence | |
Development and psychometric evaluation of a new patient-reported outcome measure for stroke self-management: The Southampton Stroke Self-Management Questionnaire (SSSMQ) | ||||
Boger EJ1, Hankins M2, Demain SH3, Latter SM4. | ||||
1Faculty of Health Sciences, University of Southampton, Southampton, SO17 1BJ, UK. 2Real-World Evidence Solutions, IMS Health, London, N1 9JY, UK. 3Faculty of Health Sciences, University of Southampton, Southampton, SO17 1BJ, UK.4Faculty of Health Sciences, University of Southampton | ||||
Health and Quality of Life Outcomes |
||||
, Article | ||||
, England | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Methodology, Oncology, Pain | 2015 | English | , Database Study, Quality of life | |
Exploring innovative methods to identify patient subgroup treatment response | ||||
J Rigg, M Hankins, A Roddam, A Avorn, J Kim | ||||
31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management August 22-26, 2015. Hynes Convention Center Boston, MA USA. |
||||
, Conference | ||||
, England | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance, Methodology | 2015 | English | , Methodology, Observational study | |
Reducing and quantifying over-fitting in regression models | ||||
John Rigg, Matthew Hankins | ||||
IMS Health, London, UK | ||||
ISPOR 20th Annual International Meeting, May 16 - 20 2015, Philadelphia, PA USA |
||||
, Conference | ||||
, England | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2015 | English | ||
Use of ADH antagonists results in lower hospital resource usage: a retrospective cohort study | ||||
Paul Grant 1 , Clare Jamookeeah 2 , Penny Dhanjal 2 & Gethin Griffith 2 | ||||
1Royal Sussex County Hospital, Brighton, UK; 2Otsuka Pharmaceuticals (UK) Ltd, Wexham, UK. | ||||
Endocrine Abstracts (2015) 38 P20 | DOI: 10.1530/endoabs.38.P20 |
||||
, Abstract | ||||
, UK | ||||
Abstract: https://www.endocrine-abstracts.org/ea/0038/ea0038p20 | ||||
Condition | Year | Language | Analysis type | |
, Guidelines, Hematology, Methodology | 2015 | English | , Burden of illness, direct to patient research, Retrospective cohort analysis, Review | |
Dose-response Network Meta-Analysis to address Dose Heterogeneity in a cost-effectiveness analysis in acute Migraine | ||||
Reason T1, Dias S2, Welton N2 | ||||
1IMS Health, London, UK, 2University of Bristol, Bristol, UK | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam |
||||
, Poster | ||||
Abstract: http://www.ispor.org/Event/ProgramList/2014Amsterdam?type=Poster&sess=IV | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2014 | English | , Meta analysis | |
ENCePP-HTA Working Group 2014 survey of members experience in conducting research to support HTA | ||||
Blake K1, Toussi M2, Kurz X1, Lis Y3, Ehrenstein V4, Qizilbash N5, Moore N6 | ||||
1 for the ENCePP-HTA Working Group, European Medicines Agency, London, UK 2 IMS Health, Paris, France 3 Parexel, London, UK 4 Aarhus University Hospital, Aarhus, Denmark 5 Oxon Epidemiology Ltd, London, UK 6 University of Bordeaux, Bordeaux, France | ||||
17th European Congress of ISPOR |
||||
, Abstract | ||||
, Europe | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2014 | English | , Survey research, Workshop | |
Improving Propensity Scoring through Machine Learning | ||||
Rigg JA1, Lodhi H1, Gregson J2, Kim J1 | ||||
1 IMS Health, London, UK 2 London School of Hygiene & Tropical Medicine, UK | ||||
Pharmacoepidemiology & Therapeutic Risk Management (ICPE), October 24-27, 2014 at the Taipei International Convention Center |
||||
, Oral presentation | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2014 | English | , Epidemiological study, Methodology | |
Proportionality between Adverse Events Identified in Spontaneous Reporting Databases and Population-Based Estimates of Drug Exposure | ||||
Kim J1, Gaskin M1, Prieto-Merino D2, Meeraus W2, Thomson A2, Collier A1, Evans SJW2 | ||||
1 IMS Health, London, UK2 London School of Hygiene & Tropical Medicine, London, UK | ||||
Pharmacoepidemiology & Therapeutic Risk Management (ICPE), October 24-27, 2014 at the Taipei International Convention Center. |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2014 | English | , Epidemiological study | |
Using an innovative approach to build a prospective Diabetes Cohort Registry Of Patients with type 2 Diabetes in Germany: Diareg (PRM 61) | ||||
Garcia Alvarez L1, Rathmann W2, Bode-Greuel K3, Engelhard J3, Busch S4, Schröder-Bernhardi D3, Hiller J1 | ||||
1IMS Health, London, UK, 2German Diabetes Center, Duesseldorf, Germany, 3IMS Health, Frankfurt am Main, Germany, 4AstraZeneca, Hamburg Area, Germany | ||||
ISPOR 17th Annual European Conference, Amsterdam 8 - 12 November 2014 |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Methodology | 2014 | English | , Methodology | |
Real-world evidence in Asia Pacific: Are we ready? Challenges and novel approaches to generating evidence in the absence of real-world data | ||||
Willford J1, Eggleston A2, Caputo J1 | ||||
1 IMS Health Asia Pacific, Singapore 2 Sanofi, Singapore | ||||
ISPOR 17th Annual European Congress, 8th – 12th November 2014, Amsterdam |
||||
, Symposium | ||||
, Asia Pacific | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2014 | English | , Real World Data | |
ENCePP-HTA Working Group survey on capacity to conduct research in support of health technology assessment | ||||
Toussi M1, Lis Y2, Qizilbash N3, Blake KV4, Ehrenstein V5, Kurz X4, Moore N6, Sinclair M | ||||
1 IMS Health, Paris, France 2 Parexel, London, UK 3 Oxon Epidemiology Ltd, London, UK 4 European Medicines Agency, London, UK 5 Aarhus University Hospital, Denmark 6 University of Bordeaux, Bordeaux, France | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2014 | English | , Survey research | |
Identifying psoriasis and psoriatic arthritis patients in retrospective databases when diagnosis code is not available: A validation study comparing medication/prescriber visit based algorithms to diagnosis codes | ||||
Dobson-Belaire W1, Borrelli R1, Goodfield J1, Liu FF2, Khan ZM3 | ||||
1IMS Brogan, Mississauga, ON, Canada, 2Celgene Inc., Mississauga, ON, Canada, 3Celgene Corporation, Summit, NJ, USA | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Rheumatology | 2014 | English | , Retrospective database analysis | |
How to bridge the gap between requirements of regulatory and health technology assessment authorities for post-authorization studies? Examples from Europe and Asia | ||||
Toussi M1, Moor N2, Chan KA3, Wong ICK4 | ||||
1 IMS Health, Paris, France 2 University of Bordeaux, France 3 University of Taipei, Taiwan 4 University of Hong Kong | ||||
30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Oct 24-27, 2014, Taipei International Convention Center |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2014 | English | , Database Study | |
ENCePP-HTA Working Group 2014 Survey of Members Experience in Conducting Research to Support HTA | ||||
Blake K1, Toussi M2, Kurz X1, Lis Y3, Ehrenstein V4, Qizilbash N5, Moore N 6 | ||||
1 European Medicines Agency, UK 2 IMS Health, Paris, France 3 PAREXEL International, Uxbridge, UK 4 Aarhus University Hospital, Denmark 5 OXON Epidemiology, Madrid, Spain 6 University of Bordeaux, France | ||||
30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Oct 24-27, 2014, Taipei International Convention Center |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Methodology | 2014 | English | , Survey research | |
Real-world evidence in Asia-Pacific: are we ready? Challenges and novel approaches to generating evidence in the absence of real-world data | ||||
Willford J1, Eggleston A2, Caputo J1 | ||||
1 IMS Health Asia Pacific, Singapore 2 Sanofi, Singapore | ||||
ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014 |
||||
, Poster | ||||
, Asia Pacific | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2014 | English | , Real World Evidence | |
Transforming oncology outcomes research through data linkage in Sweden: A unique real-world lens on the entire patient journey | ||||
Sobocki P | ||||
IMS Health, Stockholm, Sweden | ||||
AccessPoint, 2014, May; 4(8): 21-25 |
||||
, Article | ||||
, Nordic, Sweden | ||||
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Oncology | 2014 | English | , Real World Evidence | |
Research question-driven data selection: A comparison of real-world insights in non-small cell lung cancer | ||||
Chen CC, Pokras S, Wade R | ||||
IMS Health, Parsippany, USA | ||||
AccessPoint, 2014, May; 4(8): 40-45 |
||||
, Article | ||||
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Oncology | 2014 | English | , Real World Evidence | |
Simultaneous development of PRO instruments intended for global use | ||||
Wada K1, Daniels S2, Arbuckle A3, Crawford B4 | ||||
1 Adelphi Values, Tokyo, Japan 2 Allergan, Inc., Irvine, CA, USA 3 Adelphi Values Ltd., Bollington, UK 4 Real World Evidence Solutions, Japan & APAC, IMS Health KK, Tokyo, Japan | ||||
ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014 |
||||
, Workshop | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2014 | English | , Real World Evidence | |
Conducting outcomes research using electronic databases in Asia Pacific | ||||
Chaiyakunapruk N1, Chiou C-F2, Crawford B3 | ||||
1 Monash University Malaysia, Selangor, Malaysia 2 Janssen Asia Pacific, Singapore, Singapore 3 Real World Evidence Solutions, Japan & APAC, IMS Health KK, Tokyo, Japan | ||||
ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014 |
||||
, Workshop | ||||
, Asia Pacific | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2014 | English | , Real World Data | |
Regression discontinuity designs: an approach to the evaluation of treatment efficacy in primary care using observational data | ||||
O'Keeffe AG, Geneletti S, Baio G, Sharples LD, Nazareth I & Petersen I | ||||
Boston University School of Medicine Clinical Epidemiology Unit | ||||
BMJ 2014; 8;349:g5293 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.bmj.com/content/349/bmj.g5293 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Methodology | 2014 | English | , Retrospective database analysis | |
Evaluation of two-fold fully conditional specification multiple imputation for longitudinal electronic health record data. | ||||
a,Catherine A. Welch 1, Irene Petersen1, Jonathan W. Bartlett 2, Ian R. White 3, Louise Marston 1, Richard W. Morris 1, Irwin Nazareth 1, Kate Walters 1 and James Carpenterb 1,4 | ||||
1, Department of Primary Care and Population Health, University College London (UCL), London, U.K. 2, Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, U.K. 3, MRC Biostatistics Unit, Cambridge, U.K. 4, MRC Clinical Trials Unit, Aviation House, Kingsway, London, U.K | ||||
Statistics in Medicine Article first published online: 30 APR 2014 DOI: 10.1002/sim.6184 Statistics in Medicine 20;33(21):3725-37 |
||||
, Article | ||||
, UK | ||||
Abstract: http://onlinelibrary.wiley.com/doi/10.1002/sim.6184/abstract | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Methodology | 2014 | English | , Database Study, Retrospective database analysis | |
Multi-level Network Meta-Analysis to account for Dose-Response and Class Effects | ||||
Reason T1, Dias S2, Welton N2 | ||||
1IMS Health, London, UK, 2University of Bristol, Bristol, UK | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam |
||||
, Poster | ||||
Abstract: http://www.ispor.org/Event/ProgramList/2014Amsterdam?type=Poster&sess=IV | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2014 | English | , Meta analysis | |
Effects of a computerized decision support system in improving pharmacological management in high-risk cardiovascular patients: A cluster-randomized open-label controlled trial | ||||
Mazzaglia G1, Piccinni C2, Filippi A1, Sini G1, Lapi F1, Sessa E1, Cricelli I1, Cutroneo P3, Trifirò G4, Cricelli C1, Caputi AP3 | ||||
1Italian College of General Practitioners, Italy.2University of Bologna, Italy.3University of Messina, Italy. 4University of Messina, Italy; Erasmus University Medical Center, The Netherlands. | ||||
Health Informatics Journal, Epub 2014 Sep 10 |
||||
, Abstract | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Methodology | 2014 | English | , Retrospective database analysis | |
Risk of ESRD and Death in Patients with CKD Not Referred to a Nephrologist: A 7-Year Prospective Study | ||||
Minutolo R1, Lapi F2, Chiodini P3, Simonetti M2, Bianchini E2, Pecchioli S2, Cricelli I2, Cricelli C4, Piccinocchi G4, Conte G5, De Nicola L5. | ||||
1Division of Nephrology and roberto.minutolo@unina2.it. 2Health Search, Italian College of General Practitioners, Florence, Italy; and. 3Medical Statistics Unit, Second University of Naples, Naples, Italy; 4Italian College of General Practitioners, Florence, Italy. 5Division of Nephrology and. | ||||
Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1586-93 |
||||
, Abstract | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Nephrology | 2014 | English | , Retrospective database analysis | |
Demystifying the propensity scoring method in real-world evidence generation | ||||
Noibi S1, Schabert V2 | ||||
1IMS Health, London, UK, 2IMS Health, Woodland Hills, USA | ||||
AccessPoint, May 2013; Vol 3(6);36-39 |
||||
, Article | ||||
Abstract: http://issuu.com/ims_heor_publications/docs/rwe_accesspoint_6_-_080513f_epub | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2013 | English | , Real World Evidence | |
A new simple primary care morbidity score predicted mortality and better explains between practice variations than the Charlson index. | ||||
Carey IM, Shah SM, Harris T, Dewilde S & Cook DG | ||||
J Clin Epidemiol. 2013 Apr;66(4):436-44. doi: 10.1016/j.jclinepi.2012.10.012. Epub 2013 Feb 8. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23395517 | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2013 | English | ||
A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases. | ||||
Coloma PM, Avillach P, Salvo F, Schuemie MJ, Ferrajolo C, Pariente A, Fourrier-Reglat A, Molokhia M, Patadia V, Van Der Lei J, Sturkenboom M, Trifiro G. | ||||
Department of Medical Informatics, Erasmus Medical Center, Postbus 2040, 3000, CA, Rotterdam, The Netherlands. | ||||
Drug Saf. 2013 Jan;36(1):13-23. doi: 10.1007/s40264-012-0002-x |
||||
, Article | ||||
, Europe | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23315292 | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Methodology | 2013 | English | , Retrospective database analysis | |
An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance. | ||||
Zhou X, Murugesan S, Bhullar H, Liu Q, Cai B, Wentworth C & Bate A | ||||
Cegedim | ||||
Drug Saf. 2013 Feb;36(2):119-34. doi: 10.1007/s40264-012-0009-3. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23329543 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Methodology | 2013 | English | , Retrospective database analysis | |
Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project. | ||||
Avillach P1, Coloma PM, Gini R, Schuemie M, Mougin F, Dufour JC, Mazzaglia G, Giaquinto C, Fornari C, Herings R, Molokhia M, Pedersen L, Fourrier-Réglat A, Fieschi M, Sturkenboom M, van der Lei J, Pariente A, Trifirò G; EU-ADR consortium.Fieschi M, Sturkenboom M, van der Lei J, Pariente A, Trifirò G; EU-ADR consortium. | ||||
1, LESIM, ISPED, University Bordeaux Segalen, Bordeaux,France 2,LERTIM, EA 3283, Faculté de Médecine, Université AixMarseille 2, Marseille, France 3,Department of Medical Informatics, Erasmus University Medical Center, Rotterdam,The Netherlands 4,Regional Health Agency of ARS, Florence, Italy 5,Health Search—Italian College of General Practitioners,Florence, Italy 6,Pedianet—Societa’ Servizi Telematici SRL, Padova, Italy 7,Centre on Public Health,University of Milano-Bicocca,Milano, Italy 8, PHARMO Coöperation UA,Utrecht, The Netherlands 9,Department of Primary Care and Public Health Sciences, Kings College, London,UK 10 Aarhus University Hospital,Århus Sygehus, Denmark 11 INSERM U 657, University Bordeaux Segalen, Bordeaux,France 12Department of Epidemiology,Erasmus University Medical Center, Rotterdam, The Netherlands 13, Department of Clinical and Experimental Medicine and Pharmacology, Section of Pharmacology, University of Messina, Messina, Italy | ||||
J Am Med Inform Assoc. 2013 Jan 1;20(1):184-92. doi: 10.1136/amiajnl-2012-000933. Epub 2012 Sep 6. |
||||
, Article | ||||
, Europe, Italy | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22955495 | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Methodology | 2013 | English | , Retrospective database analysis | |
Harmonizing Methods and Data across Multiple Databases: Beautiful Music or Cacophony? | ||||
Zhou X, Sturkenboom M, Haynes K, Ryan PB, Bourke AD, Bate A. | ||||
29th ICPE Montreal |
||||
, Conference | ||||
Abstract: http://www.pharmacoepi.org/pub/09DDEEBB-9ECC-7DB3-89E5-8C1F5B93B016 | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2013 | English | , Database Study | |
Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases. | ||||
Schuemie MJ, Gini R, Coloma PM, Straatman H, Herings RM, Pedersen L, Innocenti F, Mazzaglia G, Picelli G, Van Der Lai J, Sturkenboom MC. | ||||
Drug Saf. 2013 Oct;36 Suppl 1:S159-69. doi: 10.1007/s40264-013-0109-8. |
||||
, Article | ||||
, Europe, Italy | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24166232 | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Methodology | 2013 | English | , Methodology, Retrospective database analysis | |
Risk identification in Healthcare Records: comparison to epidemiological studies. | ||||
Edwards IR1, Karimi G1, Bergvall T1, Caster O1, Asiimwe A2, Star K1, Bhayat F3, Soriano-Gabarro M4, Thakrar B5, Thompson M6, Bate A7 & Norén GN1 | ||||
1 Uppsala Monitoring Centre, Uppsala, Sweden. 2 Eli Lilly UK, Surrey, United Kingdom. 3 Takeda (TGRD), London, United Kingdom. 4 Bayer Pharma AG, Berlin, Germany. 5 F Hoffmann-La Roche, Basel, Switzerland, 6 Cegedim Strategic Data Medical Research Ltd, London, United Kingdom. 7 Pfizer UK, Surrey, United Kingdom 6. Cegedim | ||||
29th International Conference on Pharma, coepidemiology and Therapeutic Risk Management (ICPE), Montreal, Canada |
||||
, Poster | ||||
, UK | ||||
Abstract: http://www.imi-protect.eu/documents/IREdwardsetalRiskidentificationinHealthcareRecordscomparisontoepidemiologicalstudiesICPEAug2.pdf | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Methodology | 2013 | English | , Retrospective database analysis | |
Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey | ||||
Gini R1, Francesconi P, Mazzaglia G, Cricelli I, Pasqua A, Gallina P, Brugaletta S, Donato D, Donatini A, Marini A, Zocchetti C, Cricelli C, Damiani G, Bellentani M, Sturkenboom MC, Schuemie MJ.Bellentani M, Sturkenboom MC, Schuemie MJ. | ||||
1Agenzia regionale di sanità della Toscana, Via Pietro Dazzi 1, 50141 Florence, Italy | ||||
BMC Public Health 2013, 13:15 doi:10.1186/1471-2458-13-15 |
||||
, Article | ||||
, Italy | ||||
Abstract: http://www.biomedcentral.com/1471-2458/13/15 | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2013 | English | , Retrospective database analysis | |
Study designs in observational research: Ensuring credible and efficient evidence generation | ||||
Surinach Lara N1, Makin C2 | ||||
1IMS Health, Barcelona, Spain, 2IMS Health, Falls Church, USA | ||||
AccessPoint, May 2013; Vol 3(6); 40-43 |
||||
, Article | ||||
Abstract: http://issuu.com/ims_heor_publications/docs/rwe_accesspoint_6_-_080513f_epub | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2013 | English | , Market impact, Observational study, Real World Data, Real World Evidence | |
Optimizing EMR database value using natural language processing | ||||
Toussi M1 | ||||
1IMS Health, France | ||||
AccessPoint, May 2013; Vol 3(6); 30-35 |
||||
, Article | ||||
, France | ||||
Abstract: http://issuu.com/ims_heor_publications/docs/rwe_accesspoint_6_-_080513f_epub | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2013 | English | , Methodology | |
Individualized treatment of HBeAg-negative CHB using peg-interferon alfa-2a as first-line and week 12 HBV-DNAHBsAg stopping rule. A cost-effectiveness analysis. | ||||
IONNAZZO Sergio (1) ; COCO Barbara (2) ; BRUNETTO Maurizia R. (2) ; ROSSETTI Francesco (3) ; CAPUTO Antonietta (3) ; LATOUR Andrea (4) ; ESPINOS Belen (5) ; BONINO Ferruccio (6) | ||||
(1) IMS Health Economics Et Outcomes Research, Milan, ITALIE (2) Hepatology Unit, Pisa University Hospital (AOUP), Pisa, ITALIE (3) Roche Spa, Monza, ITALIE (4) IMS Health Economics Et Outcomes Research, London, ROYAUME-UNI (5) IMS Health Economics Et Outcomes Research, Barcelona, ESPAGNE (6) General Medicine II Digestive and Liver Disease Unit, Pisa University Hospital (AOUP), Pisa, ITALIE | ||||
Antivir Ther. 2013;18(4):623-33. |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Methodology | 2013 | English | , Cost of illness, Methodology | |
Mille general practice governance (MilleGPG): an interactive tool to address an effective quality of care through the Italian general practice network. | ||||
Cricelli I1, Lapi F, Montalbano C, Medea G, Cricelli C. | ||||
1Italian College of General Practitioners, Florence, Italy | ||||
Prim Health Care Res Dev. 2013 Oct;14(4):409-12 |
||||
, Abstract | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Methodology | 2013 | English | , Retrospective database analysis | |
Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries | ||||
Coloma PM, Valhoff VE, Mazzaglia G, Nielsson MS, Pedersen L, Molokhia M, Mosseveld M, Morabito P, Schuemie MJ, Van Der Lei J, Sturkenboom M, Trifiro G, EU-ADR Consortium. | ||||
Department of Medical Informatics, Erasmus MC University Medical Center, Rotterdam, The Netherlands. | ||||
BMJ Open2013;3:e002862 doi:10.1136/bmjopen-2013-002862 |
||||
, Article | ||||
, Europe, Italy | ||||
Abstract: http://bmjopen.bmj.com/content/3/6/e002862.abstract | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Methodology | 2013 | English | , Retrospective database analysis | |
Alternative outcome definitions and their effect on the performance of methods for observational outcome studies | ||||
Christian G. Reich • Patrick B. Ryan • Martijn J. Schuemie | ||||
C. G. Reich (&) AstraZeneca PLC, 35 Gatehouse Drive, Waltham, MA 02451, USA e-mail: reich@omop.org P. B. Ryan Janssen Research and Development LLC, Titusville, NJ, USA M. J. Schuemie Department of Medical Informatics, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands C. G. Reich P. B. Ryan M. J. Schuemie Observational Medical Outcomes Partnership, Foundation for the National Institutes of Health, Bethesda, MD, USA | ||||
Drug Saf. |
||||
, Article | ||||
, USA | ||||
Abstract: DOI 10.1007/s40264-013-0111-1 | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Observational Health Data Sciences and Informatics (OHDSI) collaboration | 2013 | English | , Database Study, Real World Data | |
Random number generators in Monte Carlo simulation | ||||
McEwan P1, Foos V2, Chraibi M3, Lloyd A4, Palmer JL5, Lamotte M6, Grant D4 | ||||
1HEOR Consulting, Monmouth, Monmouthshire, UK, 2IMS Health, Basel, Basel-Stadt, Switzerland, 3Institute for Advanced Simulation, Jülich, Germany, 4IMS Health, London, UK, 5IMS Health, Allschwil, Basel-Landschaft, Switzerland, 6IMS Health, Vilvoorde, Belgium | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters4.aspx | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2012 | English | , Methodology | |
Minimum run-time requirements to reduce Monte Carlo error in stochastic simulations | ||||
Foos V1, McEwan P2, Lloyd A3, Palmer JL4, Lamotte M5, Grant D3 | ||||
1IMS Health, Basel, Basel-Stadt, Switzerland, 2HEOR Consulting, Monmouth, Monmouthshire, UK, 3IMS Health, London, UK, 4IMS Health, Allschwil, Basel-Landschaft, Switzerland, 5IMS Health, Vilvoorde, Belgium | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters4.aspx | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2012 | English | , Methodology | |
Correlating cost effectiveness output with patient level data input via the IMS Core Diabetes Model (CDM) | ||||
McEwan P1, Foos V2, Lloyd A3, Palmer JL4, Lamotte M5, Grant D3 | ||||
HEOR Consulting, Monmouth, Monmouthshire, UK, 2IMS Health, Basel, Basel-Stadt, Switzerland, 3IMS Health, London, UK, 4IMS Health, Allschwil, Basel-Landschaft, Switzerland, 5IMS Health Consulting Group, Vilvoorde, Belgium | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters4.aspx | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2012 | English | , Cost effectiveness | |
Does the CAT questionnaire produce similar results when self- or interviewer-administered? | ||||
Badia X1, Agusti A2, Soler JJ3, Molina J4, Cenoz S5, Roset M6, Garcia-Losa M7 | ||||
1 IMS Health, Barcelona, Spain, 2 Hospital ClÃnic IDIBAPS, Barcelona, Spain, 3 Hospital de Requena, (Valencia), Spain, 4 Centro de Salud Francia, Madrid, Spain, 5 GlaxoSmithKline, Tres Cantos, Madrid, Spain, 6 IMS Health, Barcelona, Spain, 7 IMS Health, Madrid, Spain | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Poster | ||||
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters4.aspx | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2012 | English | , Methodology | |
Hepatitis C virus in Asia: utility values based on the Short Form-36 questionnaire. | ||||
Crawford B 1, Yeung CK 1, Tanaka E 1, Kraemer M 2, Leteneux C2. | ||||
1. Adelphi Values, Arco Tower 12F, 1-8-1 Shimomeguro, Meguro-ku, Tokyo 153-0064, Japan 2. Novartis Pharmaceuticals, Novartis Campus, Fabrikstr. 6-5. 09.2, CH-4056 Basel, Switzerland | ||||
Expert Rev Pharmacoecon Outcomes Res. 2012 Dec;12(6):765-73. doi: 10.1586/erp.12.61. |
||||
, Article | ||||
, Asia Pacific | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23252358 | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Methodology | 2012 | English | , Survey research | |
A comparison between prescribing in THIN data and dispensing in England. | ||||
Thompson M, Dattani H, Bourke A, MacLachlan S, Lloyd D & Faulding S. | ||||
EuroDURG/ISPE meeting University of Antwerp 2011 |
||||
, Poster | ||||
, UK | ||||
Abstract: http://csdmruk.cegedim.com/THINBibliography.pdf | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2012 | English | ||
A simple approach to improve recording of concerns about child maltreatment in primary care records: developing a quality improvement intervention. | ||||
Woodman J, Allister J, Rafi I, de Lusignan S, Belsey J, Petersen I & Gilbert R | ||||
UCL Institute of Child Health | ||||
Br J Gen Pract. 2012 Jul;62(600):e478-86. doi: 10.3399/bjgp12X652346. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22781996 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Methodology, Pediatrics | 2012 | English | , Retrospective database analysis | |
An algorithm to identify medical practices common to both the General Practice Research Database and The Health Improvement Network database. | ||||
Cai B, Xu W, Bortnichak E & Watson DJ | ||||
Pfizer Inc. Epidemiology, Worldwide Safety Strategy | ||||
Pharmacoepidemiol Drug Saf. 2012 Jul;21(7):770-774. doi: 10.1002/pds.3277. Epub 2012 Apr 30. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22544805 | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2012 | English | , Retrospective database analysis | |
Using electronic health care records for drug safety signal detection: a comparative evaluation of statistical methods. | ||||
Schuemie MJ1, Coloma PM, Straatman H, Herings RM, Trifirò G, Matthews JN, Prieto-Merino D, Molokhia M, Pedersen L, Gini R, Innocenti F, Mazzaglia G, Picelli G, Scotti L, van der Lei J, Sturkenboom MC. | ||||
1Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands | ||||
Med Care. 2012 Oct;50(10):890-7. |
||||
, Article | ||||
, Europe, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22929992 | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Methodology | 2012 | English | , Retrospective database analysis | |
USING MAPPED EQ-5D FROM DISEASE-SPECIFIC MEASURES IN COST-UTILITY ANALYSIS: WHAT IS THE CURRENT STATE IN ASIA PACIFIC? | ||||
Leartsakulpanitch J, Crawford B, Lee EK, Chiou CF. | ||||
ISPOR 5th Asia-Pacific Conference Taipei International Convention Center, Taiwan September 4th, 2012 |
||||
, Poster | ||||
, Asia Pacific | ||||
Abstract: http://www.ispor.org/conferences/Taipei0912/ReleasedPresentations/IP4Slides-Leartsakulpanitch-Chiou.pdf | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2012 | English | ||
Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. | ||||
Blak BT, Thompson M, Dattani H & Bourke A | ||||
Cegedim | ||||
Inform Prim Care. 2011;19(4):251-5. |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22828580 | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2012 | English | , Retrospective database analysis | |
An algorithm to identify medical practices common to both the General Practice Research Database and The Health Improvement Network database. | ||||
Bing Cai1, Weifeng Xu2, Edward Bortnichak3 andDouglas J. Watson3, | ||||
1Epidemiology, Worldwide Safety Strategy, Pfizer Inc., Collegeville, PA, USA 2Biostatics and Research Decision Sciences, Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA 3Department of Epidemiology, Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA | ||||
Pharmacoepidemiol Drug Saf. 2012 Jul;21(7):770-774. doi: 10.1002/pds.3277. Epub 2012 Apr 30. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22544805 | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2012 | English | , Retrospective database analysis | |
Combining electronic healtcare databases in Europe to allow for large-scale drug safety monitoring : the EU-ADR Project. | ||||
Coloma PM, Schuemie MJ, trifiro G, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Giaquinto C, Corrao G, Pedersen L, Van Der Lei J, Sturkenboom M, EU-ADR Consortium. | ||||
Pharmacoepidemiol Drug Saf. 2011 Jan;20(1):1-11. doi: 10.1002/pds.2053. Epub 2010 Nov 8. |
||||
, Article | ||||
, Denmark, Italy, Netherlands, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21182150 | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2011 | English | ||
Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records. | ||||
Toh S, GarcÃa RodrÃguez LA & Hernán MA | ||||
Harvard Medical School/Harvard Pilgrim Health Care Institute Department of Population Medicine | ||||
Pharmacoepidemiol Drug Saf. 2011 Aug;20(8):849-57. doi: 10.1002/pds.2152. Epub 2011 Jun 30. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21717528 | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2011 | English | , Retrospective database analysis | |
EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection. | ||||
Trifiro G, Patadia V, Schuemie MJ, Coloma PM, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, giaquinto C, Scotti L, Avillach P, Sturkenboom MC, van der Lei J, Eu-Adr group. | ||||
Stud Health Technol Inform. 2011;166:25-30. |
||||
, Article | ||||
, Denmark, Italy, Netherlands, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21685607 | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2011 | English | ||
IS IT FEASIBLE TO COLLECT QUALITY OF LIFE DATA ELECTRONICALLY IN THIN - A UK GENERAL PRACTICE DATABASE? | ||||
Blak BT , Lee J, Thompson M, Bourke A, Pinder A | ||||
Cegedim | ||||
ISPOR 16th Annual International Meeting Baltimore, USA ISPOR 2011 |
||||
, Poster | ||||
, UK | ||||
Abstract: http://www.researchgate.net/publication/241110439_PRM10_IS_IT_FEASIBLE_TO_COLLECT_QUALITY_OF_LIFE_DATA_ELECTRONICALLY_IN_THIN_-_A_UK_GENERAL_PRACTICE_DATABASE | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2011 | English | , Retrospective database analysis | |
Temporal and within practice variability in the health improvement network. | ||||
Haynes K, Bilker WB, Tenhave TR, Strom BL & Lewis JD | ||||
Pharmacoepidemiol Drug Saf. 2011 Sep;20(9):948-55. doi: 10.1002/pds.2191. Epub 2011 Jul 13. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21755569 | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2011 | English | ||
Quality of chronic disease care for older people in care homes and the community in a primary care pay for performance system: retrospective study | ||||
Shah SM, Carey IM, Harris T, DeWilde S & Cook DG | ||||
St George's University of London Division of Population Health Sciences and Education | ||||
BMJ 2011;342:d912 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.bmj.com/content/342/bmj.d912 | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2011 | English | , Retrospective database analysis | |
Validity of The Health Improvement Network (THIN) for the study of psoriasis. | ||||
Seminara NM, Abuabara K, Shin DB, Langan SM, Kimmel SE, Margolis D, Troxel AB & Gelfand JM | ||||
University of Pennsylvania Department of Dermatology | ||||
Br J Dermatol. 2011 Mar;164(3):602-9. doi: 10.1111/j.1365-2133.2010.10134.x. Epub 2011 Feb 3. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064479/ | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Methodology | 2011 | English | , Retrospective database analysis | |
Temporal and within practice variability in the health improvement network | ||||
Haynes K, Bilker WB, TenHave TR & Lewis JD | ||||
University of Pennsylvania School of Medicine Department of Biostatistics and Epidemiology | ||||
Pharmacoepidemiol Drug Saf. 2011 Sep;20(9):948-55. doi: 10.1002/pds.2191. Epub 2011 Jul 13. |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21755569 | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2011 | English | , Retrospective database analysis | |
Validation of a common data model for active safety surveillance research. | ||||
J Marc Overhage,1,2 Patrick B Ryan,2,3,4 Christian G Reich,2 Abraham G Hartzema,2,5 Paul E Stang2,3 | ||||
1Regenstrief Institute, Indiana University, School of Medicine, Indianapolis, Indiana, USA 2Observational Medical Outcomes Partnership, Foundation for the National Institutes of Health, Bethesda, Maryland, USA 3Johnson & Johnson Institute, Department of Pharmaceutical Research and Development LLC, Titusville, New Jersey, USA 4UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA 5College of Pharmacy, University of Florida, Gainesville, Florida, USA | ||||
J Am Med Inform Assoc |
||||
, Article | ||||
, USA | ||||
Abstract: doi:10.1136/amiajnl-2011-000376 | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Methodology | 2011 | English | , Database Study, Real World Data | |
Identifying the clinical characteristics of older people living in care homes using a novel approach in a primary care database | ||||
Shah SM, Carey IM, Harris T, DeWilde S, Hubbard R, Lewis S & Cook DG | ||||
Division of Community Health Sciences, St George's University of London | ||||
Age Ageing. 2010 Sep;39(5):617-23. doi: 10.1093/ageing/afq086. Epub 2010 Jul 16. |
||||
, Article | ||||
, UK | ||||
Abstract: http://ageing.oxfordjournals.org/content/39/5/617.long | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2010 | English | , Retrospective database analysis | |
Lessons Learned from Mapping the THIN Database to the Observational Medical Outcome Partnership (OMOP) Common Data Model (CDM) | ||||
Zhou X, Murugesan S, Wentworth C, Bhullar H & Bate A | ||||
Cegedim | ||||
Pharmacoepidemiology and Drug Safety (19): S1-S347 |
||||
, Poster | ||||
, UK | ||||
Abstract: http://gpdr01.hosting.uk.uu.net/our-data/accessing-the-data.html | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2010 | English | , Retrospective database analysis | |
Case validation in research using large databases | ||||
GarcÃa RodrÃguez LA & Ruigómez A | ||||
Department of Primary Health Care, University of Oxford, Oxford, UK | ||||
Br J Gen Pract. 2010 Mar;60(572):160-1. doi: 10.3399/bjgp10X483472. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20202361 | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2010 | English | , Retrospective database analysis | |
Has the Quality and Outcomes Framework Influenced Primary Care Data Recording? | ||||
Blak BT, Lee J, Hards M & Sedani T | ||||
Cegedim | ||||
ISPOR, 13th Annual European Congress Prague, Czech Republic Value in Health 13(7):A416 |
||||
, Poster | ||||
, UK | ||||
Abstract: http://www.ispor.org/congresses/Prague1110/posters3.aspx | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2010 | English | , Retrospective database analysis | |
HOW DO THIN DEATH DATA COMPARE TO NATIONAL FIGURES FOR EACH UK COUNTRY? | ||||
Blak BT, Hards M & Lee J | ||||
Cegedim | ||||
ISPOR, 13th Annual European Congress Prague, Czech Republic Value in Health 13 (7):A331 |
||||
, Article, Poster | ||||
, UK | ||||
Abstract: http://www.ispor.org/congresses/Prague1110/posters2.aspx | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2010 | English | , Retrospective database analysis | |
Missing Data in Primary Care Databases; Problems and a Possible Solution | ||||
Marston L, Carpenter J, Walters K, Morris R, Nazareth I & Petersen I | ||||
Department of Primary Care and Population Health, University College London | ||||
UCL 2010 |
||||
, Abstract | ||||
, UK | ||||
Abstract: https://www.ucl.ac.uk/pcph/research-groups-themes/thin-pub/research_presentations/Louise_ISPE_2010 | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2010 | English | , Retrospective database analysis | |
An algorithm to identify practices common to both the GPRD and THIN Databases. | ||||
Cai B, Xu W, Bortnichak E & Watson DJ | ||||
Epidemiology, Worldwide Safety Strategy, Pfizer Inc., Collegeville, PA | ||||
Pharmacoepidemiology and Drug Safety (19): S1-S347 |
||||
, Abstract | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2010 | English | , Retrospective database analysis | |
The application of discrete even simulation to quantitative risk benefit analysis | ||||
Maguire A, Douglas I & Blak BT | ||||
Cegedim | ||||
Value in Health 12(7):A453 |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://researchonline.lshtm.ac.uk/4488/ | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2009 | English | , Retrospective database analysis | |
The importance of defining periods of complete mortality reporting for research using automated data from primary care | ||||
Maguire A, Blak B T & Thompson M | ||||
Cegedim | ||||
Pharmacoepidemiol Drug Saf. 2009 Jan;18(1):76-83. doi: 10.1002/pds.1688. |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19065600 | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2009 | English | , Retrospective database analysis | |
A Globally Optimal k-Anonymity Method for the De-identification of Health Data. | ||||
KHALED EL EMAM, PHD, FIDA KAMAL DANKAR, PHD, ROMEO ISSA, MS, ELIZABETH JONKER, BA, DANIEL AMYOT, PHD, ELISE COGO, ND, JEAN-PIERRE CORRIVEAU, PHD, MARK WALKER, MS, MD, SADRUL CHOWDHURY, MS, REGIS VAILLANCOURT, BPHARM, PHARMD, TYSON ROFFEY, BA, JIM BOTTOMLEY, BSCH, MHA | ||||
Children’s Hospital of Eastern Ontario Research Institute (KEE, FKD, EJ, EC, RV, TR, JB), Ottawa, Ontario, Canada; Pediatrics, Faculty of Medicine (KEE), School of Information Technology and Engineering (DA, SC), University of Ottawa, Ottawa, Ontario, Canada; School of Computer Science (RI, J-PC), Carleton University, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute (MW), Ottawa, Ontario, Canada. | ||||
Journal of the American Medical Informatics Association |
||||
, Article | ||||
, Canada | ||||
Abstract: https://watermark.silverchair.com/jamia.m3144.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAh8wggIbBgkqhkiG9w0BBwagggIMMIICCAIBADCCAgEGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMV_JYq2YeyT3x7ZGGAgEQgIIB0m8zmdADRJniIyvyVCYC8USRD7o4BkEOoK4uF65LmDb24pXAbafplEsE8JYZFNlsfioGMd3VElD1BCSdQiMP3whzpkqiJKOY9QBvdmwATCq79TkYj0mYawUN3N7_8FJeJcBSX2QBw93JwWk3qsBmtdcrBx7JuUeIvEiqfKP_T_U5_7V61pveujmYMOG-7oaa5q3plG1aj_DIzsj84UOdvL_Tr1rsv0zOOJoSTtsUuDVz7vXHuIFhhXhgtzRkZ2BDJYU1dN9bjIumrVJLcEkVEJRyJqGL5arzFn5CyHnUMPwuU4xNMok8JS_fdYrJhRz_POHRHHITCk9lqy6xtfIZV8Q1X8LhlO3QAHgyl6yX3wkktjGEfB7KHop1heWnTV5jFo95UFO4s1CtN_CmhDQxv_I139JdablwNc8BCCqNVXgDGcix1HOFWccp1LWxnLO_D2loe7bZgb_oPeHxmazvNH_PP8PK_2NlfxRQ98FXGryUlm7A-Otjg_HZJb_2bMlEI07sLnI1n9x9YOHJT5ZqMTbgfROrqs8J7dxSG0j7GLoOB04_4tBWmBRhWP1HOwROwFuJDW9chF5spZfkEu0w26WV9UxFN0LssqYFhhrxgTXZWnQ | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2009 | English | , De-identification / anonymisation | |
Internationale Trends in der pharmazeutischen Industrie [International trends in the pharmaceutical industry]. | ||||
Aitken M1, Fricke F-U2, Reichelt A2 | ||||
1 IMS Health, Norwalk, USA 2 IMS Health, Nuremberg, Germany | ||||
Schöffski O, Fricke F-U, Guminski W (ed.). Pharmabetriebslehre, Berlin-Heidelberg, Springer, 2008, 445-456 |
||||
, Book chapter | ||||
Abstract: http://www.springerlink.com/index/ptk87p6790882038.pdf | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2008 | German | ||
Evalutionsforschung [Evaluation research] | ||||
Schöffski O1, Fricke F-U2 | ||||
1 University Erlangen-Nuremberg, Germany 2 IMS Health, Nuremberg, Germany | ||||
Schöffski O, Fricke F-U, Guminski W (ed.). Pharmabetriebslehre, Berlin-Heidelberg, Springer, 2008, 73-87 |
||||
, Book chapter | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2008 | German | , Methodology | |
The importance of defining periods of complete mortality reporting in automated patient databases | ||||
Maguire A, Blak BT, Thompson M & Hall G | ||||
24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ISPE) |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2008 | English | ||
The impact of different resource cost definitions on results, interpretations, and comparability of health economic studies | ||||
Tunis SL1, Pelletier EM2, St. Charles M1, McEwan P3. | ||||
1IMS Health, Noblesville, IN, USA, 2IMS Health, Watertown, MA, USA, 3Cardiff Medicentre, University Hospital of Wales, Cardiff, UK | ||||
ISPOR 10th Annual European Meeting, 2007, October, Dublin, Ireland |
||||
, Workshop | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Methodology | 2007 | English | , Methodology, Retrospective database analysis | |
Asthma Control in Spain. Do season and treatment pattern matter? ESCASE study. | ||||
Fueyo A, Ruiz MA, Ancochea J, Guilera M, Badia X on behalf of the ESCASE group. | ||||
Respir Med 2007;101(5): 919-924 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2007 | English | ||
The imperative for demonstrating the value of medicines | ||||
Lambert, Tina | ||||
UK Times newspaper 29 January 2007 |
||||
, Press release | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2007 | English | ||
Can you hear me now? Techniques for effectively communicating value to internal and external decision makers. | ||||
Jonothan Tierce , Claude LePen , Adrian Kielhorn , Elisabeth Hazard | ||||
ISPOR 2007 10th Annual European Congress |
||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2007 | English | ||
The impact of different resource cost definitions on results, interpretations, and comparability of health economic studies. | ||||
Tunis SL1, Pelletier EM1, St. Charles M1, McEwan P2 | ||||
1IMS Health, Inc., Watertown, MA, USA, 2 | ||||
International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 10th Annual European Meeting, Dublin, Ireland, October 2007 |
||||
, Workshop | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Methodology, Miscellaneous | 2007 | English | , Retrospective database analysis | |
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. | ||||
Lewis JD, Schinnar R, Bilker WB, Wang X & Strom BL | ||||
Department of Medicine, University of Pennsylvania School of Medicine | ||||
Pharmacoepidemiol Drug Saf. 2007 Apr;16(4):393-401. |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17066486 | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2007 | English | , Retrospective database analysis | |
Quality of life: definition and concepts. | ||||
Badia X, Lizán L. | ||||
MartÃnez MartÃn, P. Quality of life in neurology. Barcelona: Ars Medica, 2006. p. 3-18 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2006 | English | , Quality of life | |
The Anthropology of Big Pharma | ||||
Sharma, D. | ||||
Health Affairs Volume 26 Number 2 |
||||
, Book review | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2006 | English | , Review | |
Direct to Patient Information (DTPI): a review of the opinions, initiatives and applications. | ||||
Badia X. | ||||
Update Seminar for journalists. Madrid (Spain) 23-24 November |
||||
, Oral presentation | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2006 | English | , Review | |
Economics, expenditures and evaluations | ||||
Brown B1, Kotchie R2, Tilden D1 | ||||
1 IMS Health UK, London, UK 2 IMS Consulting, London, UK | ||||
Pharmaceutical Marketing 2006 Supplement |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2006 | English | , Economic evaluation | |
Demonstrating value to new stakeholders | ||||
Kotchie R | ||||
www.scripsupplements.com |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2006 | English | , Pricing & Reimbursement | |
White book on odontology profession future in Catalonia: evolution scenarios | ||||
Health Outcomes Research Europe Group. | ||||
Col.legi Oficial d'Odontòlegs i Estomatòlegs de Catalunya; 2006. |
||||
, Book | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2006 | Spanish | , Methodology | |
La aportación de los antibióticos a la salud. | ||||
Health Outcomes Research Europe Group. | ||||
Fundación Farmaindustria; 2004. |
||||
, Book | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2006 | Spanish | ||
Drug pricing and reimbursement policy. In: Fundación Cotec para la innovación tecnológica | ||||
Badia X, ValentÃn C, Elvira D | ||||
BiotecnologÃa en la medicina del futuro. Madrid: Cotec; 2006. p. 48-53. |
||||
, Book chapter | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2006 | Spanish | , Pricing & Reimbursement | |
Designing and developing budget impact models suited for global adaptation. | ||||
Smith TW, Tierce JC. | ||||
ISPOR Connections. 2006; 12(4). |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2006 | English | ||
Vers une convergence des modes de financement ? in Mondialisation et Santé. | ||||
Actes du Colloque du Cercle des Economistes, Paris, 27 avril, 2006. |
||||
, Manuscript in preparation | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2006 | French | ||
Direct to Patient Information on prescription drugs: economic and health impact in public health in Spain. | ||||
Badia X. | ||||
Press lunch organized by MSD on DTPI 2006 6 July, Madrid, Spain |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2006 | English | , Review | |
Can pharmaceutical industry use reps to provide medical practice guidelines (Migraine and asthma) | ||||
Chaix-couturier C, Benis E, Calles B, Collomb D, Anhoury P | ||||
, Oral presentation | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2006 | English | ||
Challenges in obtaining ethical approval for a pilot study to obtain biosamples in a UK medical records database | ||||
Haynes K, Thompson M, Dattani H, Bourke A & Hennessy S | ||||
Cegedim | ||||
Pharmacoepidemiology and Drug Safety 15:(S1):S137-138 |
||||
, Abstract, Poster | ||||
, UK | ||||
Abstract: https://www.yumpu.com/en/document/view/25281501/final-program-2006-international-society-for-pharmacoepidemiology/7 | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2006 | English | , Retrospective database analysis | |
Has the Quality and Outcomes Framework (QOF) Scheme Impacted upon General Practitioners’ (GPs) Clinical Practice? | ||||
Blak BT, Dattani H, Bourke A & Page M | ||||
`Cegedim | ||||
The National Institute of Clinical Excellence (NICE) conference Birmingham, UK |
||||
, Poster | ||||
, UK | ||||
Abstract: http://www.docstoc.com/docs/15295324/THIN-Publications-_excel_---EPIC-Database-Research-Company-Ltd | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2006 | English | , Retrospective database analysis | |
National Representativeness and Data Quality of the Health Improvement Network (THIN) Database of Primary Care Information for Epidemiological Research | ||||
Blak BT, Thompson M & Bourke A | ||||
Cegedim | ||||
9th Annual Conference of the UK Federation of Primary Care Research Organisations Liverpool, UK |
||||
, Poster | ||||
, UK | ||||
Abstract: http://www.docstoc.com/docs/15295324/THIN-Publications-_excel_---EPIC-Database-Research-Company-Ltd | ||||
Condition | Year | Language | Analysis type | |
, Methodology, Miscellaneous | 2006 | English | , Retrospective database analysis | |
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research | ||||
Lewis JD, Schinnar R, Bilker WB, Wang X & Strom BL | ||||
Department of Medicine, University of Pennsylvania School of Medicine | ||||
Pharmacoepidemiol Drug Saf. 2007 Apr;16(4):393-401. Pharmacoepidemiology and Drug Safety15: (S1):S233-234 |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17066486 | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2006 | English | , Retrospective database analysis | |